Hematological Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Octagam 10% Approved

The FDA has approved Octagam 10% liquid preparation for the treatment of adults with chronic immune thrombocytopenic purpura (ITP).

New Drug Product: Alprolix

Prevention and control of bleeding in hemophilia B.

New Hem. A Therapy, Less Injections

The FDA has approved Eloctate (coagulation factor VIII [recombinant], Fc fusion protein; Biogen Idec) for use in adults and children with hemophilia A.

Generic Cyklokapron Injection Approved

Acella announced the approval of an Abbreviated New Drug Application for Tranexamic Acid Injection, the generic version of Pfizer's Cyklokapron.

Soliris Vials Found With Visible Particles

Alexion announced a voluntary recall of certain lots of Soliris (eculizumab) 300mg/30mL concentrated solution for IV infusion.

First Gene-Based Test for Transfusion

The first molecular assay used in transfusion medicine to determine blood compatibility has been approved by the FDA.

Breakthrough Therapy for Leukemia

The FDA has granted Breakthrough Therapy designation to blinatumomab for adults with Philadelphia-negative (Ph-) relapsed/refractory acute lymphoblastic leukemia.

Anticoagulant Dosing Conversions

Review this chart on 'Anticoagulant Dosing Conversions' for quick information when you need it.

Featured courses from mycme

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Vertebroplasty is effective for managing myelomatous VCFsExternal web site

Nurse awareness of this treatment option and the patient selection criteria may be a significant ...

CE 0.60 Credits

Transformative Changes in the Management of Multiple MyelomaExternal web site

Physicians may be hesitant to apply a patient-tailored approach to multiple myeloma treatment, especially with ...

CME 0.50 Credits

Sign Up for Free e-newsletters